PrimeGene (Beijing)

Beijing, China · Founded 2016 · Privately Held (backing)

Operator of an innovative pharmaceutical company intended to be specialized in innovative drug research, clinically valuable generic drug development and pharmaceutical industrialization. PrimeGene (Beijing) is based in Beijing, China and was founded in 2016. Its last reported valuation was $248 million in Jan 2025. It has raised $85.6 million.

Last reported valuation

$248.0M

Oct 2026

Priced at

—

Total raised

$85.6M

Last round

—

How much has PrimeGene (Beijing) raised?

$85.6Macross 0 recorded rounds

Free account

More of PrimeGene (Beijing) with a free account

·Watch PrimeGene (Beijing): the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

PrimeGene (Beijing) investors

8 investors are on record for PrimeGene (Beijing), including Beijing State-owned Capital Operation and Management, K2VC, Shun Xi Fund and Lapam Capital.

For fundraisers

Raising for a company like PrimeGene (Beijing)?

8 investors have backed PrimeGene (Beijing).

See all 8 investors →

Frequently asked about PrimeGene (Beijing)

How much has PrimeGene (Beijing) raised?: PrimeGene (Beijing) has raised $85.6M in total across 0 recorded funding rounds.